Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Guidance

Subcategories:Clinical Criteria/GuidelinesEthicsLegal UpdatesLegislation & AdvocacyMeeting ReportsResearch Rheum

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

High-resolution computed tomography shows evidence of ILD.

The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!

 

Ethics Forum: The Ethical Side of End-of-Life Decisions

C. Ronald MacKenzie, MD  |  September 5, 2012

The role of the consulting physicians in the ICU, the concept of medical futility, and the management of complex patients when the goals of care may be changing.

EULAR 2012: Partnership Between Physician and Patient

Thomas R. Collins  |  September 5, 2012

Patient involvement a valuable tool, especially in less common rheumatic disorders.

Extended Warranties for Medical Equipment

Steven M. Harris, Esq.  |  September 5, 2012

The art of purchasing a piece of medical equipment requires the perfect combination of medical, financial, business, and legal expertise.

Why Did Rheumatoid Arthritis Begin in 1800?

Staff  |  September 5, 2012

The connection between periodontal disease and RA.

Neutralizing IL-23 and Its Targets May Improve Ankylosing Spondylitis

Lara C. Pullen, PhD  |  August 30, 2012

Researchers have identified a unique population of entheseal resident cells that can be activated by interleukin 23 (IL-23). This finding may be key to understanding how dysregulation of IL-23 results in precise inflammation of the entheses.

Newly Discovered Molecule Modulates Cartilage Repair

Lara C. Pullen, PhD  |  August 29, 2012

Chondrocytes play an important role in cartilage repair as well as symptom relief. Research published in Science provides insights into the role of stem cell–based therapies in the promotion of chondrogenesis and cartilage repair.

EULAR 2012: Remission the New Normal for Rheumatoid Arthritis

Thomas R. Collins  |  August 8, 2012

Advances in the rheumatology clinic are promising, two experts say.

Partners in Advancing Rheumatology

James O’Dell, MD, and David I. Daikh, MD, PhD  |  August 8, 2012

The REF is making great strides in advancing treatment and finding cures for rheumatic disease.

AMA House of Delegates Meeting: Decisions Affecting You

Gary Bryant, MD  |  August 8, 2012

An overview of some of the issues that were covered during the June 2012 American Medical Association House of Delegates meeting to debate policy.

Outstanding ARHP Program Planned for the ACR/ARHP Annual Meeting

Afton L. Hassett, PsyD  |  August 8, 2012

The primary tracks at the meeting will focus on clinical practice, clinical science, basic science, and business/administration; four subtracks will include sessions relevant for educators, those interested in pediatrics, practice managers, and rheumatology trainees.

  • « Previous Page
  • 1
  • …
  • 251
  • 252
  • 253
  • 254
  • 255
  • …
  • 307
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences